Aclaris Therapeutics (NasdaqGS:ACRS) 2025 Conference November 12, 2025 01:20 PM ET Speaker2Awesome. Good afternoon, everyone. It's my pleasure to introduce the Aclaris Therapeutics team. Hugh Davis, Roland Kolbeck, and Will Roberts here joining us this afternoon. Maybe we could start off with just a brief overview of the company. Maybe, Hugh, do you want to start with that?Speaker1Sure. Yeah, hi. Thanks for having us. Aclaris is a clinical stage biotech. We have three assets in the clinic and another to com ...

Aclaris Therapeutics (NasdaqGS:ACRS) FY Conference November 12, 2025 11:00 AM ET Speaker2Ready to go?Yep.Excellent.Speaker1Okay, good morning, everybody, and thanks again for joining us. This is Guggenheim's Healthcare Innovations Conference. I'm really, I'm Seamus Fernandez, one of the senior biopharma analysts here at Guggenheim. You know, really pleased to have with us Aclaris Therapeutics, and immediately to my right is Dr. Neal Walker, CEO and Chair of Aclaris. Also, joining us in the audience is Kevin ...